On this special episode of the Kingscrowd Podcast, we’re joined by Gerry Hays, founder and CEO of Doriot. Gerry shares the vision behind Venture Staking, a new model designed to revolutionize early-stage investing by allowing investors to secure future investment rights at minimal upfront costs. Later, Kingscrowd’s Senior Investment Associate Teddy Lyons breaks down the latest healthcare and pharma trends in Regulation Crowdfunding (RegCF) and Regulation A (RegA) markets, highlighting surprising data on funding growth and investor behavior.
Highlights include…
Special Guest Gerry Hays: Understanding Venture Staking and its impact on crowdfunding
Venture Staking Model: Why securing the right to invest could be better than investing upfront
Healthcare Funding Trends: Surprising insights into RegCF and RegA performance in biotech and pharma
